Search
Gyre Therapeutics Inc
GYREAdd to Watchlist
7.340USD
+0.820+12.58%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
670.67MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025Q3
By BusinessUSD
Name
Revenue
Proportion
ETUARY
27.69M
90.61%
Etorel
1.54M
5.05%
Contiva
1.25M
4.07%
Other Products
81.00K
0.27%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
ETUARY
27.69M
90.61%
Etorel
1.54M
5.05%
Contiva
1.25M
4.07%
Other Products
81.00K
0.27%